Search clinical trials for: Detergent

Total 669 results

California Pacific Medical Center Research Institute

Completed

Study of Naltrexone for Methamphetamine Addiction

Methamphetamine Dependence

United States
Pacific Institute for Research and Evaluation
Cephalon

Completed

Vivitrol for Reducing Driving While Impaired Behavior Among Repeat Offenders

Alcohol Consumption

United States
Oregon Health and Science University
National Institute on Drug Abuse (NIDA); Johns Hopkins University; University... and other collaborators

Completed

Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up

Hiv | Opioid-use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA); Baystate Medical Center

Completed

Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations (NewHope)

HIV | Opioid Dependence | AIDS | Drug Dependence

United States
University of Pennsylvania

Completed

Understanding Treatment Response With Naltrexone Among White Alcoholics (DEFINE II)

Alcoholism

United States
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism

Alcohol Dependence

United States
University of Wisconsin, Madison

Completed

Attenuation of Pain in Men and Women

Pain

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Employment-Based Depot Naltrexone Clinical Trial II

Opiate Dependence

United States
The University of Texas Health Science Center,...
National Institute on Drug Abuse (NIDA)

Completed

Combined Treatment for Cocaine-Alcohol Dependence - 1

Alcohol Dependence | Cocaine Dependence

United States
US Department of Veterans Affairs

Terminated

Pilot Study of Depot NTX in Homeless Veterans

Alcohol Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence

Opiate Dependence

United States
Rigshospitalet, Denmark

Completed

Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism? (LDN-in-FM)

Fibromyalgia

Denmark
University of California, Los Angeles
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Naltrexone for Individuals of East Asian Descent

Alcohol Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone (Depot-BNT)

Heroin Dependence | Opiate Dependence

United States
Katy Peters

Completed

Low Dose Naltrexone for Glioma Patients

Malignant Glioma

United States
NYU Langone Health
Alkermes, Inc.

Completed

Extended-release Naltrexone for Alcohol Dependence in Primary Care

Alcohol Dependence

United States
University of North Carolina, Chapel Hill
National Institute on Alcohol Abuse and Alcoholism (NIAAA); Lipha Pharmaceuticals

Completed

COMBINE (Acamprosate/Naltrexone)

Alcoholism

United States
Weill Medical College of Cornell University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

Naltrexone Treatment for Prolonged Grief Disorder (PGD) (PGD)

Prolonged Grief Disorder

United States
Oregon Health and Science University
National Institute on Drug Abuse (NIDA)

Completed

Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study (CHOICES)

Opioid Use Disorder | Alcohol Use Disorder

Canada, United States
GlaxoSmithKline

Completed

To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers

Alcoholism

United Kingdom
The Scripps Research Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Naltrexone Maintenance Treatment of Alcoholism

Alcoholism

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1

Heroin Dependence

United States
Bausch Health Americas, Inc.

Completed

Pharmacokinetics and Bioavailability of Single Subcutaneous Doses of Methylnaltrexone Versus Intravenous Dose

Healthy Subjects

United States
Milton S. Hershey Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); The...

Completed

The Effects of Naltrexone on Active Crohn's Disease (LDN)

Inflammation | Crohn's Disease

United States
Milton S. Hershey Medical Center

Completed

The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease (LDN-Ped)

Crohn's Disease

United States
The Scripps Research Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Medication Development in Alcoholism: Acamprosate Versus Naltrexone

Alcoholism

United States
Rhode Island Hospital
National Institute on Drug Abuse (NIDA); Alkermes, Inc.

Completed

Pre-Release VIVITROL for Opioid Dependent Inmates

Substance-Related Disorders

United States
Stanford University
American Fibromyalgia Syndrome Association

Completed

Effects of Low Dose Naltrexone in Fibromyalgia

Fibromyalgia | Persian Gulf Syndrome

United States
Mclean Hospital

Completed

Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects (Zyprexa)

Psychotic Disorders | Schizophrenia

United States
University of Miami

Completed

Optimizing Pharmacotherapy for Bipolar Alcoholics

Alcohol Dependence | Bipolar Disorder

United States
NYU Langone Health
Alkermes, Inc.; New York City Department of Health and Mental Hygiene

Completed

Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail

Opiate Dependence

United States
Indiana University School of Medicine
Brown University; George Washington University; VA Boston Healthcare System

Completed

Research on Individualized Treatment for Alcoholism (RITA)

Alcohol Dependence

United States
University of Utah
Cantex Pharmaceuticals

Terminated

Study of Disulfiram and Copper Gluconate in Patients With Treatment-Refractory Multiple Myeloma (Repurpose-1)

Multiple Myeloma

United States
University of California, San Francisco
National Institute on Drug Abuse (NIDA)

Completed

Intermittent Naltrexone Among Polysubstance Users (Project iN)

Methamphetamine | Alcohol

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence - 1

Alcoholism | Cocaine Dependence

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Effects of Naltrexone on Nicotine Reinforcement

Tobacco Dependence

United States
National Institute on Alcohol Abuse and Alcoholism...

Completed

Naltrexone Treatment of Alcohol Dependence

Alcoholism

United States
Hospital for Special Surgery, New York

Not yet recruiting

Low Dose Naltrexone Therapy for Complex Regional Pain Syndrome (LDN-CRPS)

Chronic Pain | Complex Regional Pain Syndrome | Causalgia | Complex Regional Pain Syndrome Type I | Complex Regional Pain Syndrome Type II

United States
University of Calgary

Not yet recruiting

Low Dose Naltrexone Use in Patients With POTS

Postural Orthostatic Tachycardia Syndrome
Go Medical Industries Pty Ltd
National Institute on Drug Abuse (NIDA); Columbia University; New York State... and other collaborators

Completed

The O'Neil Long Acting Naltrexone Implant (OLANI) Pharmacokinetic (PK)/Safety Study in Healthy Volunteers

Opioid Use Disorder

United States
New York State Psychiatric Institute

Terminated

Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol

Opioid-use Disorder

United States
Masonic Cancer Center, University of Minnesota

Terminated

Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer

Breast Cancer

United States
San Francisco Department of Public Health
National Institute on Drug Abuse (NIDA); Alkermes, Inc.

Completed

Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM) (TREX)

Amphetamine-Related Disorders

United States
University of Pennsylvania
Michael J. Fox Foundation for Parkinson's Research

Completed

Naltrexone for Impulse Control Disorders in Parkinson's Disease

Parkinson Disease | Impulse Control Disorder

United States
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Behavioral Therapy Plus Naltrexone for Alcoholism

Alcohol Dependence | Alcoholism

United States
Indiana University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Post-Treatment Effects of Naltrexone

Alcoholism

United States
Baxter Healthcare Corporation

Completed

Efficacy and Safety Study of Fibrin Sealant With 4 IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS VH S/D 4) in Face-Lift Procedures

Facial Rhytidectomy (Face-lift)

United States
Go Medical Industries Pty Ltd
National Institute on Drug Abuse (NIDA); Columbia University; University at Buffalo and other collaborators

Not yet recruiting

Evaluation of the O'Neil Long Acting Naltrexone Implant in Opioid Dependent Persons (GM0020)

Opioid Use Disorder
University of California, San Francisco
The CARESTAR Foundation

Terminated

Emergency Department Initiated Extended-Release Naltrexone and Case Management for the Treatment of Alcohol Use Disorder

Substance Use | Alcohol Use Disorder | Alcohol Abuse or Dependence

United States
University of Chicago

Completed

Naltrexone in the Treatment of Trichotillomania

Trichotillomania

United States

Search clinical trials for: Detergent

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations